Home
Leadership
Science
- Senescence
- Diseases
Data
Media
- News
- Videos
Partners
Contact

BIO Investor Forum

Home / Events / BIO Investor Forum

17Oct 2016 by siwa-admin-2017

copy here

Search for:

About Us

SIWA Therapeutics is a privately held preclinical stage biotechnology company that has a monoclonal antibody that targets and destroys senescent cells.

Recent News

DR. THOMAS TANG JOINS SIWA THERAPEUTICS SCIENTIFIC ADVISORY BOARD
Third Annual Healthspan Extension Policy and Regulation Workshop
Second Annual Healthspan Extension Policy and Regulation Workshop

JOIN OUR MAILING LIST

Navigation

Home
Leadership
Science
- Senescence
- Diseases
Data
Media
- News
- Videos
Partners
Contact